Turn Therapeutics, Inc. (TTRX)
8.095
-0.54
(-6.31%)
USD |
NASDAQ |
Nov 20, 16:00
8.095
0.00 (0.00%)
After-Hours: 20:00
Turn Therapeutics Research and Development Expense (TTM) : 1.225M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.225M |
| June 30, 2026 | 0.7781M |
| Date | Value |
|---|---|
| March 31, 2026 | 0.3657M |
| December 31, 2025 | 0.2656M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Journey Medical Corp. | 0.259M |
| ANI Pharmaceuticals, Inc. | 50.60M |
| Corcept Therapeutics, Inc. | 241.72M |
| Veru, Inc. | 11.76M |
| Johnson & Johnson | 16.02B |